Literature DB >> 24126874

Cancer cachexia: getting to the heart of the matter.

John D Groarke1,2, Susan Cheng2, Lee W Jones3, Javid Moslehi1,2.   

Abstract

Entities:  

Year:  2019        PMID： 24126874      PMCID： PMC6801934          DOI： 10.1093/eurheartj/eht424

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  15 in total

1.  Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival.

Authors:  Xiaolan Zhou; Jin Lin Wang; John Lu; Yanping Song; Keith S Kwak; Qingsheng Jiao; Robert Rosenfeld; Qing Chen; Thomas Boone; W Scott Simonet; David L Lacey; Alfred L Goldberg; H Q Han
Journal:  Cell       Date:  2010-08-20       Impact factor: 41.582

2.  Prevention of liver cancer cachexia-induced cardiac wasting and heart failure.

Authors:  Jochen Springer; Anika Tschirner; Arash Haghikia; Stephan von Haehling; Hind Lal; Aleksandra Grzesiak; Elena Kaschina; Sandra Palus; Mareike Pötsch; Karoline von Websky; Berthold Hocher; Celine Latouche; Frederic Jaisser; Lars Morawietz; Andrew J S Coats; John Beadle; Josep M Argiles; Thomas Thum; Gabor Földes; Wolfram Doehner; Denise Hilfiker-Kleiner; Thomas Force; Stefan D Anker
Journal:  Eur Heart J       Date:  2013-08-29       Impact factor: 29.983

3.  Randomized comparison of megestrol acetate versus dexamethasone versus fluoxymesterone for the treatment of cancer anorexia/cachexia.

Authors:  C L Loprinzi; J W Kugler; J A Sloan; J A Mailliard; J E Krook; M B Wilwerding; K M Rowland; J K Camoriano; P J Novotny; B J Christensen
Journal:  J Clin Oncol       Date:  1999-10       Impact factor: 44.544

4.  A placebo-controlled, double-blind trial of infliximab for cancer-associated weight loss in elderly and/or poor performance non-small cell lung cancer patients (N01C9).

Authors:  Aminah Jatoi; Howard L Ritter; Amylou Dueck; Phuong L Nguyen; Daniel A Nikcevich; Ronnie F Luyun; Bassam I Mattar; Charles L Loprinzi
Journal:  Lung Cancer       Date:  2009-08-08       Impact factor: 5.705

Review 5.  Definition and classification of cancer cachexia: an international consensus.

Authors:  Kenneth Fearon; Florian Strasser; Stefan D Anker; Ingvar Bosaeus; Eduardo Bruera; Robin L Fainsinger; Aminah Jatoi; Charles Loprinzi; Neil MacDonald; Giovanni Mantovani; Mellar Davis; Maurizio Muscaritoli; Faith Ottery; Lukas Radbruch; Paula Ravasco; Declan Walsh; Andrew Wilcock; Stein Kaasa; Vickie E Baracos
Journal:  Lancet Oncol       Date:  2011-02-04       Impact factor: 41.316

6.  Skeletal muscle mRNA levels for cathepsin B, but not components of the ubiquitin-proteasome pathway, are increased in patients with lung cancer referred for thoracotomy.

Authors:  R Thomas Jagoe; Christopher P F Redfern; Russell G Roberts; G John Gibson; Timothy H J Goodship
Journal:  Clin Sci (Lond)       Date:  2002-03       Impact factor: 6.124

Review 7.  Cancer cachexia: it's time for more clinical trials.

Authors:  Maurizio Bossola; Fabio Pacelli; Antonio Tortorelli; Giovan Battista Doglietto
Journal:  Ann Surg Oncol       Date:  2006-11-09       Impact factor: 5.344

8.  Insulin treatment in cancer cachexia: effects on survival, metabolism, and physical functioning.

Authors:  Kent Lundholm; Ulla Körner; Lena Gunnebo; Petra Sixt-Ammilon; Marita Fouladiun; Peter Daneryd; Ingvar Bosaeus
Journal:  Clin Cancer Res       Date:  2007-05-01       Impact factor: 12.531

Review 9.  Emerging paradigms in cardiomyopathies associated with cancer therapies.

Authors:  Bonnie Ky; Pimprapa Vejpongsa; Edward T H Yeh; Thomas Force; Javid J Moslehi
Journal:  Circ Res       Date:  2013-08-30       Impact factor: 17.367

10.  Beta-blocker drug therapy reduces secondary cancer formation in breast cancer and improves cancer specific survival.

Authors:  Desmond G Powe; Melanie J Voss; Kurt S Zänker; Hany O Habashy; Andrew R Green; Ian O Ellis; Frank Entschladen
Journal:  Oncotarget       Date:  2010-11
View more
  2 in total

1.  The AMPK agonist 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR), but not metformin, prevents inflammation-associated cachectic muscle wasting.

Authors:  Derek T Hall; Takla Griss; Jennifer F Ma; Brenda Janice Sanchez; Jason Sadek; Anne Marie K Tremblay; Souad Mubaid; Amr Omer; Rebecca J Ford; Nathalie Bedard; Arnim Pause; Simon S Wing; Sergio Di Marco; Gregory R Steinberg; Russell G Jones; Imed-Eddine Gallouzi
Journal:  EMBO Mol Med       Date:  2018-07       Impact factor: 12.137

2.  Nutritional leucine supplementation attenuates cardiac failure in tumour-bearing cachectic animals.

Authors:  Aline Tatiane Toneto; Luiz Alberto Ferreira Ramos; Emilianne Miguel Salomão; Rebeka Tomasin; Miguel Arcanjo Aereas; Maria Cristina Cintra Gomes-Marcondes
Journal:  J Cachexia Sarcopenia Muscle       Date:  2016-02-24       Impact factor: 12.910
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.